Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: Case report and literature review

Viral Immunology

Volumn 19, Issue 1, 2006, Pages 102-107

  Knysz, Brygida ^a   Bolanowski, Marek ^a   Klimczak, Malgorzata ^a   Gladysz, Andrzej ^a   Zwolinska, Katarzyna ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; HLA ANTIGEN CLASS 2; LAMIVUDINE; LIOTHYRONINE; PROPRANOLOL; PROPYLTHIOURACIL; RITONAVIR; STAVUDINE; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; VIRUS RNA;

ADULT; CASE REPORT; CD4 LYMPHOCYTE COUNT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GRAVES DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHYROIDISM; IMMUNE RECONSTITUTION SYNDROME; IMMUNOPATHOLOGY; REVIEW;

ADULT; ANTI-HIV AGENTS; ANTITHYROID AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; GRAVES DISEASE; HIV INFECTIONS; HUMANS; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33645467705     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.102     Document Type: Review

References (26)

1. Carcelain, G., P. Debre, B. Autran. Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr. Opin. Immunol. 2001;13: 483-488.
2. Chen, F., S.L. Day, R.A. Metcalfe, G. Sethi, M.S. Kapembwa, M.G. Brook, D. Churchill, A. de Ruiter, S. Robinson, C.J. Lacey, and A.P. Weetman. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine 2005;84: 98-106.
3. de Boer, M.G., F.P. Kroon, R.H. Kauffmann, R. Vriesendorp, K. Zwinderman, and J.T. van Dissel. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics. Netherlands J. Med. 2003;61: 408-412.
4. Franco, J.M., A. Rubio, M. Martinez-Moya, M. Leal, E. Merchante, A. Sanchez-Quijano, and E. Lissen. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood 2002;99:3702-3706.
5. French, M.A., N. Lenzo, M. John, S.A. Mallal, E.J. McKinnon, I.R. James, P. Price, J.P. Flexman, and M.L. Tay-Kearney. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000; 1:107-115.
6. French, M.A., S.R. Lewin, C. Dykstra, R. Krueger, P. Price, and P.J. Leedman. Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction. AIDS Res. Hum. Retroviruses 2004;20:157-162.
7. French, M.A., P. Price, and S.F. Stone. Immune restoration disease after antiretroviral therapy. AIDS 2004;18:1615-1627.
8. Fundaro, C., A. Olivieri, C. Rendeli, O. Genovese, A.M. Martino, M. D'Archivio, E. Medda, S. De Angeli, A. Plebani, F. Salvini, M. Sorcini, and G. Segni. Occurrence of anti-thyroid autoantibodies in children vertically infected with HIV-1. J. Pediatr. Endocrinol. Metab. 1998;11:745-750.
9. Gilquin, J., J.P. Viard, V. Jubault, C. Sert, and M.D. Kazatchkine. Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet 1998;352:1907-1908.
10. th Annual Meeting, pp. 179-188.
11. Hardy, G., S. Worrell, P. Hayes, C.M. Barnett, D. Glass, J. Pido-Lopez, N. Imami, R. Aspinall, J. Dutton, B. Gazzard, A.M. Peters, and P.M. Gotch. Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection. HIV Med. 2004;5:67-73.
12. Jubault, V., A. Penfornis, F. Schillo, B. Hoen, M. Izembart, J. Timsit, M.D. Kazatchkine, J. Gilquin, and Viard J.P. Sequential occurrence of thyroid autoantibodies and Graves' disease after irnmune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J. Clin. Endocrinol. Metab. 2000;85: 4254-4257.
13. Kolte, L., A.M. Dreves, A.K. Ersboll, C. Strandberg, D.L. Jeppesen, N.O. Nielsen, L.R. Ryder, and S.D. Nielsen. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J. Infect. Dis. 2002;185:1578-1585.
14. Markert, M.L., A.P. Alvarez-McLeod, G.D. Sempowski, L.P. Hale, J.M. Horvatinovich, K.J. Weinhold, J.A. Bartlett, T.A. D'Amico, and B.F. Haynes. Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 2001;17: 1635-1643.
15. Merenich, J.A., M.T. McDermott, A.A. Asp, S.M. Harrison, and G.S. Kidd. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 1990;70:566-571.
16. Mocroft, A., B. Ledergerber, C. Katlama, O. Kirk, P. Reiss, A. d'Arminio Monfoite, B. Knysz, M. Dietrich, A.N. Phillips, J.D. Lundgren; EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003;362:22-29.
17. Notermans, D.W., N.G. Pakker, D. Hamann, N.A. Foudraine, R.H. Kauffmann, P.L. Meenhorst, J. Goudsmit, M.T. Roos, P.T. Schellekens, F. Miedema, and S.A. Danner. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. J. Infect. Dis. 1999;180:1050-1056.
18. Price, P., G. Morahan, D. Huang, E. Stone, K.Y. Cheong, A. Castley, M. Rodgers, M.Q. McIntyre, L.J. Abraham, and M.A. French. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002;16:2043-2047.
19. Rubio, A., M. Martinez-Moya, M. Leal, J.M. Franco, E. Ruiz-Mateos, E. Merchante, A. Sanchez-Quijano, and E. Lissen. Changes in thymus volume in adult HIV-infected patients under HAART: correlation with the T-cell repopulation. Clin. Exp. Immunol. 2002;130:121-126.
20. Ruiz-Mateos, E., A. Rubio, A. Vallejo, R. De la Rosa, A. Sanchez-Quijano, E. Lissen, and M. Leal. Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART). Clin. Exp. Immunol. 2004;136: 501-506.
21. Sereti, I., N.J. Sarlis, E. Arioglu, M.L. Turner, and J.M. Mican. Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy. AIDS 2001;15:138-140.
22. rd, R.J. Hamill, M.C. Rodriguez-Barradas, S.B. Greenberg, R.L. Atmar, D.W. Musher, J.C. Gathe, Jr., F. Visnegarwala, and B.W. Trautner. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002;81:213-227.
23. Stoll, M., and R.E. Schmidt. Immune restoration inflammatory syndromes: the dark side of successful antiretroviral treatment. Curr. Infect. Dis. Rep. 2003;5:266-276.
24. Teixeira, L., H. Valdez, J.M. McCune, R.A. Koup, A.D. Badley, M.K. Hellerstein, L.A. Napolitano, D.C. Douek, G. Mbisa, S. Deeks, J.M. Harris, J.D. Barbour, B.H. Gross, LR. Francis, R. Halvorsen, R. Asaad, and M.M. Lederman. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001;15:1749-1756.
25. Tomer, Y., and T.F. Davies. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 2003;24:694-717.
26. Zandman-Goddard, G., and Y. Shoenfeld. HIV and autoimmunity. Autoimmun. Rev. 2002;1:329-337.